Welcome to LookChem.com Sign In|Join Free

CAS

  • or

131287-39-3

Post Buying Request

131287-39-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • L-Asparagine,N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]-

    Cas No: 131287-39-3

  • No Data

  • No Data

  • No Data

  • Antimex Chemical Limied
  • Contact Supplier

131287-39-3 Usage

Description

FMOC-ASN(AC3ACNH-BETA-GLC)-OH is a synthetic Fmoc-protected glycopeptide that features a glycan moiety attached to the side chain of asparagine. FMOC-ASN(AC3ACNH-BETA-GLC)-OH is characterized by its white to off-white powder form and is designed to enhance the recognition by glycan-dependent HIV-1 broadly neutralizing antibodies.

Uses

Used in Pharmaceutical Industry:
FMOC-ASN(AC3ACNH-BETA-GLC)-OH is used as a research compound for the development of therapeutic agents targeting HIV-1. Its enhanced recognition by glycan-dependent HIV-1 broadly neutralizing antibodies makes it a valuable tool in the design and synthesis of potential antiviral drugs.
Used in Biochemical Research:
In the field of biochemical research, FMOC-ASN(AC3ACNH-BETA-GLC)-OH serves as a key component in studying the interactions between glycoproteins and their respective antibodies. This knowledge can contribute to a better understanding of the immune response and the development of vaccines or immunotherapies.
Used in Drug Design and Development:
FMOC-ASN(AC3ACNH-BETA-GLC)-OH is utilized in the design and development of drugs that target specific glycan-dependent pathways. Its unique structure allows for the exploration of novel drug candidates that can potentially modulate these pathways for therapeutic benefits.
Used in Diagnostics:
In the diagnostics industry, FMOC-ASN(AC3ACNH-BETA-GLC)-OH can be employed in the development of assays and tests that detect the presence of specific antibodies or antigens related to glycan-dependent HIV-1 infection. This can aid in early diagnosis and monitoring of the disease progression.

Check Digit Verification of cas no

The CAS Registry Mumber 131287-39-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,1,2,8 and 7 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 131287-39:
(8*1)+(7*3)+(6*1)+(5*2)+(4*8)+(3*7)+(2*3)+(1*9)=113
113 % 10 = 3
So 131287-39-3 is a valid CAS Registry Number.

131287-39-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-4-[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]amino]-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxobutanoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:131287-39-3 SDS

131287-39-3Downstream Products

131287-39-3Relevant articles and documents

Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy

Li, Yulei,Zhang, Yihan,Wu, Minghao,Chang, Qi,Hu, Honggang,Zhao, Xia

, p. 516 - 525 (2019)

As a host defense peptide, hymenochirin-1B has attracted increasing attention for its strong cytotoxic activities. However, its poor selectivity and proteolytic stability remain major obstacles for clinical application. To solve these problems, we designed and synthesized a series of peptide analogues of hymenochirin-1B based on cationic residue substitution and stapling combined with a glycosylation strategy. Some analogues showed improvement not only in selectivity and proteolytic stability but also in antitumor activity. Among them, the glycosylated stapled peptide H-58 was identified as the most potential antitumor peptide. Flow cytometry and a competitive binding assay revealed that H-58 displayed significant antitumor selectivity. Confocal microscopy and nuclear staining with Hoechst dye demonstrated that H-58 entered the nucleus and caused DNA damage. In summary, the strategy of glycosylated stapled peptides is a promising approach for improving the antitumor selectivity, proteolytic stability, and antitumor activity of hymenochirin-1B, which can be used for other bioactive peptide modifications.

Synthesis of PNGase-resistant N-glycopeptide containing an α-anomeric glycosidic linkage

Dao, Yuankun,Dong, Suwei,Dong, Weidong,Zhang, Jun

, (2022/03/01)

N-glycans in eukaryotic proteins are commonly attached to asparagine residues via β-N-glycosidic linkages, which are susceptible to glycosidases, such as PNGase. Here we report the preparation of α-N-glycosylated peptides based on the solid-phase peptide synthesis strategy using an α-N-GlcNAc-containing asparagine building block, and a transglycosylation reaction of oligosaccharide oxazoline promoted by endoglycosidases CCN180H. The resultant glycopeptide, bearing the complex-type α-N-sialyl undecasaccharide, exhibits resistance against PNGase F, which may be of potential use in studying the catabolism of N-glycans and glycoengineering those peptide-based therapeutics.

Total Synthesis of Glycosylated Human Interferon-γ

Ashhurst, Anneliese S.,Dowman, Luke J.,Fairbanks, Antony J.,Kwan, Ann,Larance, Mark,Li, Henry Y.,Payne, Richard J.,Wang, Xiaoyi,Watson, Emma E.

, p. 6863 - 6867 (2020/09/15)

Interferon-γ(IFN-γ) is a glycoprotein that is responsible for orchestrating numerous critical immune induction and modulation processes and is used clinically for the treatment of a number of diseases. Herein, we describe the total chemical synthesis of homogeneously glycosylated variants of human IFN-γusing a tandem diselenide-selenoester ligation-deselenization strategy in the C- to N-terminal direction. The synthetic glycoproteins were successfully folded, and the structures and antiviral functions were assessed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 131287-39-3